Home » News » Clinical Intelligence » To support women entrepreneurs in biotech, MassNextGen initiative launches

To support women entrepreneurs in biotech, MassNextGen initiative launches

Monday, November 20, 2017

Takeda Pharmaceutical Company and the Massachusetts Life Sciences Center (MLSC) have formed a $1 million initiative aimed at supporting women entrepre­neurs in early-stage biotech with an eye toward addressing gender gaps in the life sciences sector. The five-year program, called the Massachu­setts Next Generation (MassNextGen) Initiative, provides funding and customized support, including mentoring from investors and industry executives, to empower women entrepreneurs and allow them to develop the network and skills necessary to become industry leaders.

Trend toward consolidation evident in merger between Chesapeake IRB and Schulman IRB

In early November, Chesapeake IRB and Schulman IRB merged to form Advarra, a new company designed to leverage mutual strengths in technology, regulatory expertise and customer service. A key goal of the merger is to address the increasingly complex needs associated with research. In fact, the new company was formed as a direct response to customers of the two IRBs, who were looking for an innovative partner to bring them state-of-the-art, superior service.


To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!